---
id: toxicological-endpoint
title: Toxicological Endpoint
description: Concept page defining toxicological endpoint with regulatory relevance.
slug: /concepts/toxicological-endpoint
sidebar_label: Toxicological Endpoint
page_type: concept
entity_class: concept
status: draft
last_reviewed: 2026-08-19
---

## Overview

A toxicological endpoint refers to a measurable biological effect or response used to assess the potential toxicity of a chemical substance. These endpoints are critical for regulatory decision-making and risk assessment in computational toxicology.

## Scope and Notes

This page defines toxicological endpoints, their role in regulatory contexts, and how they are used to evaluate chemical safety. It distinguishes between different types of endpoints, such as adverse outcomes and biomarkers.

## Key Claims or Definitions

### Definition of Toxicological Endpoint

```yaml
claim_id: clm-endpoint-001
page_id: toxicological-endpoint
claim_type: definition
statement: A toxicological endpoint is a measurable biological effect used to assess the toxicity of a chemical.
subject: Toxicological endpoint
predicate: is_a_measurable
object: biological effect
qualifiers:
  context: toxicity_assessment
citations:
  - cit-001
verification_status: supported
confidence: high
depends_on: []
notes: null
```

### Regulatory Relevance

```yaml
claim_id: clm-endpoint-002
page_id: toxicological-endpoint
claim_type: fact
statement: Toxicological endpoints are used in regulatory assessments to determine the safety of chemicals.
subject: Toxicological endpoints
predicate: are_used_in
object: regulatory assessments
qualifiers:
  context: chemical_safety
citations:
  - cit-002
verification_status: supported
confidence: high
depends_on: []
notes: null
```

## Evidence or Details

Toxicological endpoints can include physiological changes, biochemical markers, or adverse health effects observed in experimental or epidemiological studies. In computational toxicology, these endpoints are often predicted using models trained on bioactivity or assay data.

## Related Pages

- [Bioactivity](../02-concepts/bioactivity.md)
- [Assay Pages](../06-assays/)
- [Dataset Pages](../07-datasets/)

## Open Questions or Review Notes

- How can computational models improve the prediction of toxicological endpoints?
- What are the challenges in validating predicted endpoints experimentally?

## References

```yaml
citation_id: cit-001
source_type: review
title: Toxicological Endpoints in Risk Assessment
authors:
  - A. Regulator
  - B. Toxicologist
year: 2023
container: Journal of Regulatory Toxicology
doi: 10.1000/reg-tox-001
url: https://example.org/endpoint-review
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-19
pages_or_sections: Section 2
notes: Defines toxicological endpoints in regulatory contexts.
```

```yaml
citation_id: cit-002
source_type: paper
title: Predicting Toxicological Endpoints Using Computational Models
authors:
  - C. Scientist
  - D. Analyst
year: 2024
container: Computational Toxicology
doi: 10.1000/comp-tox-004
url: https://example.org/endpoint-prediction
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-19
pages_or_sections: Section 3
notes: Discusses the use of computational models in predicting endpoints.
```